In addition to genomic alterations, gene set enrichment analysis of relapsed neuroblastoma tumors identified the downregulation of genes transcriptionally silenced by the Yes-Associated Protein (YAP), a core effector of the Hippo signaling pathway, compared to diagnostic tumors, suggesting increased YAP transcriptional activity at relapse [9]. This evidence concerns the gene YAP1 and neuroblastoma.